Authors:
Kawai, S
Vora, S
Das, S
Gachie, E
Becker, B
Neufeld, AH
Citation: S. Kawai et al., Modeling of risk factors for the degeneration of retinal ganglion cells after ischemia/reperfusion in rats: effects of age, caloric restriction, diabetes, pigmentation, and glaucoma, FASEB J, 15(7), 2001, pp. 1285-1287
Citation: B. Liu et Ah. Neufeld, Nitric oxide synthase-2 in human optic nerve head astrocytes induced by elevated pressure in vitro, ARCH OPHTH, 119(2), 2001, pp. 240-245
Citation: L. Yuan et Ah. Neufeld, Tumor necrosis factor-alpha: A potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head, GLIA, 32(1), 2000, pp. 42-50
Citation: B. Liu et Ah. Neufeld, Expression of nitric oxide synthase-2 (NOS-2) in reactive astrocytes of the human glaucomatous optic nerve head, GLIA, 30(2), 2000, pp. 178-186
Citation: Ah. Neufeld et al., Cellular localization of neuronal nitric oxide synthase (NOS-1) in the human and rat retina, J COMP NEUR, 416(2), 2000, pp. 269-275
Citation: Ah. Neufeld et al., Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma, P NAS US, 96(17), 1999, pp. 9944-9948
Citation: A. Sawada et Ah. Neufeld, Confirmation of the rat model of chronic, moderately elevated intraocular pressure, EXP EYE RES, 69(5), 1999, pp. 525-531
Citation: Ah. Neufeld, Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma, ARCH OPHTH, 117(8), 1999, pp. 1050-1056
Citation: Ah. Neufeld, New conceptual approaches for pharmacological neuroprotection in glaucomatous neuronal degeneration, J GLAUCOMA, 7(6), 1998, pp. 434-438